Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 - PubMed (original) (raw)
. 2015 Mar 1;136(5):E359-86.
doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
Affiliations
- PMID: 25220842
- DOI: 10.1002/ijc.29210
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al. Int J Cancer. 2015.
Abstract
Estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. We review the sources and methods used in compiling the national cancer incidence and mortality estimates, and briefly describe the key results by cancer site and in 20 large "areas" of the world. Overall, there were 14.1 million new cases and 8.2 million deaths in 2012. The most commonly diagnosed cancers were lung (1.82 million), breast (1.67 million), and colorectal (1.36 million); the most common causes of cancer death were lung cancer (1.6 million deaths), liver cancer (745,000 deaths), and stomach cancer (723,000 deaths).
Keywords: GLOBOCAN; Incidence; cancer; global estimates; mortality.
© 2014 UICC.
Similar articles
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Ferlay J, et al. Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516. Int J Cancer. 2010. PMID: 21351269 - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Bray F, et al. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. CA Cancer J Clin. 2018. PMID: 30207593 - Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Ferlay J, et al. Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6. Int J Cancer. 2019. PMID: 30350310 - Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.
Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F. Ferlay J, et al. Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9. Eur J Cancer. 2018. PMID: 30100160 Review. - Progress in cancer mortality, incidence, and survival: a global overview.
Santucci C, Carioli G, Bertuccio P, Malvezzi M, Pastorino U, Boffetta P, Negri E, Bosetti C, La Vecchia C. Santucci C, et al. Eur J Cancer Prev. 2020 Sep;29(5):367-381. doi: 10.1097/CEJ.0000000000000594. Eur J Cancer Prev. 2020. PMID: 32740162 Review.
Cited by
- Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients.
Ma X, Zhang Z, Chen X, Zhang J, Nie J, Da L, Hu W, Tian G, Wu D, Han J, Han S, Long J, Wang Y, Fang J. Ma X, et al. Thorac Cancer. 2021 Jun;12(12):1841-1850. doi: 10.1111/1759-7714.13846. Epub 2021 May 6. Thorac Cancer. 2021. PMID: 33955685 Free PMC article. - Development of a prognostic model for hepatocellular carcinoma using genes involved in aerobic respiration.
Rao J, Wu X, Zhou X, Deng R, Ma Y. Rao J, et al. Aging (Albany NY). 2021 Apr 26;13(9):13318-13332. doi: 10.18632/aging.203021. Epub 2021 Apr 26. Aging (Albany NY). 2021. PMID: 33903282 Free PMC article. - Clinical Acceptability of Automated Radiation Treatment Planning for Head and Neck Cancer Using the Radiation Planning Assistant.
Olanrewaju A, Court LE, Zhang L, Naidoo K, Burger H, Dalvie S, Wetter J, Parkes J, Trauernicht CJ, McCarroll RE, Cardenas C, Peterson CB, Benson KRK, du Toit M, van Reenen R, Beadle BM. Olanrewaju A, et al. Pract Radiat Oncol. 2021 May-Jun;11(3):177-184. doi: 10.1016/j.prro.2020.12.003. Epub 2021 Feb 25. Pract Radiat Oncol. 2021. PMID: 33640315 Free PMC article. - Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C.
Orzechowska D, Klimowicz K, Stępień A, Mikuła T, Sapuła M, Wiercińska-Drapało A. Orzechowska D, et al. Clin Exp Hepatol. 2021 Mar;7(1):93-100. doi: 10.5114/ceh.2021.104466. Epub 2021 Mar 15. Clin Exp Hepatol. 2021. PMID: 34027121 Free PMC article. - Comparison of the clinical outcomes of skin bridge loop ileostomy and traditional loop ileostomy in patients with low rectal cancer.
Ye H, Huang S, Yu J, Zhou Q, Xi C, Cao L, Wang P, Shen J, Gong Z. Ye H, et al. Sci Rep. 2021 Apr 27;11(1):9101. doi: 10.1038/s41598-021-88674-x. Sci Rep. 2021. PMID: 33907300 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical